6 completed. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 1 | Completed 1 |
Follow Typhoid Fever: new trials by email Literature Review of Typhoid Fever trials Research Report on Typhoid Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants EuTCV (Vi-CRM Typhoid conjugate vaccine), Typbar-TCV - Typhoid Fever | Phase 2 / Phase 3 | Completed | EuBiologics Co.,Ltd | 444 | 2020-09-07 | 2021-10-07 |
| Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III) Vi-DT (Multi-dose formulation), Vi-DT (Single dose formulation), Control Vaccine - Typhoid | Phase 3 | Completed | International Vaccine Institute | 1800 | 2020-02-04 | 2021-08-27 |
| Nepal Undifferentiated Febrile Illness Trial Azithromycin, Co-trimoxazole - Undifferentiated Febrile Illness | Phase 3 | Completed | Oxford University Clinical Research Unit, Vietnam | 330 | 2016-05-23 | 2023-12-06 |
| Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects Typhoid Vi polysaccharide - Salmonella Infections, Typhoid Fever | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 200 | 2012-05-01 | 2014-05-12 |
| A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults Typhoid Vi Polysaccharide Vaccine, Yellow Fever Vaccine, Japanese Encephalitis Vaccine - Meningococcal Disease, Meningococcal Meningitis | Phase 3 | Completed | Novartis | 552 | 2011-11-01 | 2014-03-11 |
| Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity Combined Vi polysaccharide typhoid vaccine and hepatitis A vaccine- Hepatyrix - Hepatitis A | Phase 3 | Completed | GlaxoSmithKline | 1034 | 2002-05-01 | 2016-09-09 |
Bacterial Infections (1) · Encephalitis, Japanese (1) · Hepatitis A (1) · Meningitis, Meningococcal (1) · Meningococcal Infections (1) · Rabies (1) · Salmonella Infections (1) · Yellow Fever (1)
Bacterial Infections and Mycoses (6) · Enterobacteriaceae Infections (6) · Gram-Negative Bacterial Infections (6) · Infections (6) · Bacterial Infections (5) · Salmonella Infections (5) · RNA Virus Infections (2) · Virus Diseases (2) · Arbovirus Infections (1) · Brain Diseases (1) · Central Nervous System Bacterial Infections (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Central Nervous System Viral Diseases (1) · Digestive System Diseases (1)
Vi polysaccharide vaccine, typhoid (2) · Azithromycin (1) · Diphtheria Toxoid (1) · Dosage Forms (1) · Japanese Encephalitis Vaccines (1) · MenACWY-CRM vaccine (1) · Rabies Vaccines (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · Yellow Fever Vaccine (1)
EuBiologics Co.,Ltd (1) · GlaxoSmithKline (1) · International Vaccine Institute (1) · Novartis (1) · Oxford University Clinical Research Unit, Vietnam (1) · Sanofi Pasteur, a Sanofi Company (1)
Philippines (2) · Czechia (1) · Germany (1) · Japan (1) · Nepal (1)
Buddha Basnyat, MBBS,MSc,MD (1) · Josefina C Carlos, MD (1)
PMID 24873986, PMID 25308927, PMID 28969659, PMID 32991678, PMID 35664443, PMID 36774331